Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Mediators of Inflammation|November 7, 2015
The Hen or the Egg: Inflammatory Aspects of Murine MPN ModelsJonas S Jutzi, Heike L Pahl
Current Hematologic Malignancy Reports|January 8, 2025
Mutant Calreticulin in MPN: Mechanistic Insights and Therapeutic ImplicationsMifra Faiz, Merle Riedemann, Jonas S Jutzi, et al.
Hemasphere|November 15, 2019
LSD1 Inhibition Prolongs Survival in Mouse Models of MPN by Selectively Targeting the Disease CloneJonas S Jutzi, Maria Kleppe, Jennifer Dias, et al.
Leukemia|October 23, 2019
Enhanced expression of the sphingosine-1-phosphate-receptor-3 causes acute myelogenous leukemia in miceSamuel Vorbach, Albert Gründer, Fengbiao Zhou, et al.
Blood|March 10, 2018
Epigenetic regulation of NFE2 overexpression in myeloproliferative neoplasmsJan C Peeken, Jonas S Jutzi, Julius Wehrle, et al.
Leukemia|December 6, 2022
CALR-mutated cells are vulnerable to combined inhibition of the proteasome and the endoplasmic reticulum stress responseJonas S Jutzi, Anna E Marneth, María José Jiménez-Santos, et al.
The Journal of Experimental Medicine|April 17, 2013
MPN patients harbor recurrent truncating mutations in transcription factor NF-E2Jonas S Jutzi, Ruzhica Bogeska, Gorica Nikoloski, et al.
Blood|June 28, 2022
Whole-genome CRISPR screening identifies N-glycosylation as a genetic and therapeutic vulnerability in CALR-mutant MPNsJonas S Jutzi, Anna E Marneth, Michele Ciboddo, et al.
Cell Death & Disease|August 14, 2025
Lysine-specific demethylase 1 regulates hematopoietic stem cell expansion and myeloid cell differentiationHans Felix Staehle, Christoph Koellerer, Anne Marie Staehle, et al.
The Journal of Experimental Medicine|January 11, 2012
A novel murine model of myeloproliferative disorders generated by overexpression of the transcription factor NF-E2Kai B Kaufmann, Albert Gründer, Tobias Hadlich, et al.
Pageof 2